🗓️ Today is the biannual meeting of the ProCanAid consortium, which takes place in Zaragoza, Spain. As the central coordinator, we are leading the project together with our partners from the Medical Research Institute La Fe (IIS La Fe) and Universidad de Zaragoza, who are committed to driving a transformative change in this field. A major milestone of this project is the development of a new model for automatic segmentation of neurovascular bundles. Scientific evidence shows that the involvement of neurovascular bundles is related to #ProstateCancer staging and clinical variables such as overall survival or the development of metastasis, and we are currently working and advancing on this model. To learn more in depth about the project and our involvement in it, do not miss the following video: https://bit.ly/3PHV4yi *Project PLEC2021-007709 funded by MCIN/AEI/10.13039/501100011033 and by Unión Europea NExtGenerationEU/PRTR
LATEST ANNOUNCEMENT! We are set to present pioneering research in #oncology with three accepted abstracts at the upcoming prestigious American Society of Clinical Oncology (ASCO) Annual Meeting. 1️⃣ Abstract #10054 - Dr. Ana Jimenez Pastor will present new machine-learning models that excel in predicting overall survival and facilitating risk stratification in neuroblastoma patients within the large, multi-institutional PRIMAGE cohort https://lnkd.in/eU2Nr6iG 2️⃣ Abstract #e20603 - Our research reviews and analyzes the application of AI-driven radiomics from CT scans to predict oncogene mutations in non-small cell lung cancer (NSCLC) https://lnkd.in/eKNrCyKu 3️⃣ Abstract #e20611 - We also study advances the use of deep learning features combined with radiomics to predict the response to immunotherapy in advanced NSCLC cases. https://lnkd.in/euxcDCgn Learn everything about our presence at #ASCO2024 ➡ https://bit.ly/44J2sB5
Thank you very much Odelle Technology and Steven Haken for having our CEO & Co-Founder, Dr Ángel Alberich-Bayarri in your podcast. A great opportunity to discuss what we do at Quibim and share our vision of improving #patientcare and #precisionmedicine.
We are delighted to showcase our latest radiology solutions at #SERAM24, in the beautiful city of Barcelona ⭐ Meet our team at booth 14 or visit us at the #AI corner. We will show you how to employ our AI-powered solutions to improve diagnostic accuracy and streamline clinical workflows. Who will we see these days at the CCIB? Don't hesitate to stop by and say hello 👋🏻 #Radiology #PrecisionMedicine
Live from Las Vegas, our team is full steam ahead at #ASNR24, exploring the vibrant world of neuroimaging alongside industry leaders and neuroradiologists from diverse backgrounds. 🧠 It's fantastic to contribute to the exciting discussions shaping the future of neuroradiology. This time, we proudly showcase our innovative brain MRI analysis solution, QP-Brain, which offers quantitative evaluations for improved detection and a more comprehensive understanding of brain atrophy and lesions. Are you currently in Las Vegas? We look forward to meeting you! 🙌🏻 #ASNR24 #Neuroradiology #PrecisionMedicine Jason Santos Néstor Jiménez American Society of Neuroradiology
On #ClinicalTrialsDay, we recognize the complex process a new drug goes through from conception to market distribution, a path that requires considerable resources and time. With an average timeline of 12 to 15 years, the process involves extensive research, meticulous testing and lengthy regulatory approvals. However, the drug development landscape is evolving, embracing the transformative potential of #AI. Tools based on #MachineLearning could further accelerate regulatory reviews and improve real-time patient monitoring via wearable devices, pushing the boundaries of efficient drug development. Among others, Quibim is developing an AI algorithm to interpret PET/CT scans, evaluating the efficacy of novel radiotracers targeting CD8 receptors in tumors. This innovation promises to improve immunotherapy response predictions and advance clinical development. Read our most recent blog post https://bit.ly/3QRZVyS, in which our CMO Glen Weiss, MD, MBA, explores how AI is streamlining workflows and reducing costs by transforming drug development and clinical trials.
The American Society of Clinical Oncology (ASCO) Annual Meeting is a premier gathering of #oncology professionals worldwide. Discover how our latest research sets the new standards in oncology, focusing on AI-driven diagnostics and personalized medicine. We have 3 abstracts accepted. One will be presented as a poster, and the others will be published online. 🧬 Prediction of oncogene mutation status in non-small cell lung cancer leveraging radiomics from CT scans: A systematic review and meta-analysis with a special focus on artificial-intelligence-based methods. 🧬 Unleashing deep features and radiomics to enhance best overall response prediction to immunotherapy in advanced non-small cell lung cancer Please stop by our poster! Highlight Presentation by our VP of AI, Dr Ana Jimenez Pastor: 🧬 Overall survival prediction and risk stratification in patients with neuroblastoma through machine learning in the large multi-institutional PRIMAGE cohort. Our models provide superior risk stratification and survival predictions by leveraging a combination of clinical, molecular, and MR radiomics data. We are excited to engage with the global oncology community to advance these technologies further. Find more about us here 👉 https://bit.ly/44J2sB5 #ASCO24
#BSUR24 kicks off in Manchester! And this time, we are honored to be among the sponsors of this prestigious event dedicated to advancing knowledge and innovation in urology ⭐ 🫱🏼🫲🏼 Join us on the first day of the British Society of Urogenital Radiology as we explore innovative approaches to urological #healthcare, including QP-Prostate, a solution designed to detect #prostatecancer earlier. We are excited to be part of this vibrant community and contribute to the ongoing dialogue around advances in the field. Together, we will positively impact and drive progress in patient care. 👐🏻 #AIInHealthcare #Urology
To all Spanish speakers, you can't miss this podcast with Itnig - Startup Ecosystem in which our CEO and Co-Founder Dr Ángel Alberich-Bayarri dives into his experience with entrepreneurship and highlights the importance of taking risks to innovate in the #MedTech field. Some takeaways: 💻 By creating software algorithms for medical image analysis we aid in diagnosing diseases and help doctors with detection. 🔎 Advancing medical imaging with #AI we facilitate virtual biopsies and fast decision making in preventive care. 📈 Implementing cost-effective strategies can improve accessibility and affordability of diagnostic medical tests for patients, #healthcare providers and insurers. Watch the full episode here ⬇
🩶 May marks #BrainCancerAwarenessMonth, a time dedicated to raising awareness about the complexities of brain tumors and the urgent need for advanced research and better treatment options in the field. 🎗️ At Quibim, we recognize the importance of spreading awareness and fostering a deeper understanding of #braincancer. By educating ourselves and supporting ongoing research, we can all significantly impact the lives of those battling this disease. #FightBrainCancer #AwarenessMatters
